Journal of the National Comprehensive Cancer Network

- PET in Cervical Cancer
- Targets, Trials, and Travails in Pancreas Cancer
- Early Detection and Biomarkers in Pancreatic Cancer
- Adjuvant Therapy for Stage II Colon Cancer
- Evidence for Raloxifene as a Breast Cancer Risk Reduction Agent
- Counterpoint: The Case for Immediate Active Treatment
- Point: Active Surveillance for Favorable Risk Prostate Cancer